You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CRS

Showing 1 - 25 of 1,905
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV I Infection Trial in Worldwide (Estradiol)

Not yet recruiting
  • HIV I Infection
  • San Diego, California
  • +25 more
Aug 15, 2023

HIV-1-infection Trial in Brazil, United States (ChAdOx1.tHIVconsv1, ChAdOx1.HIVconsv62, MVA.tHIVconsv3)

Not yet recruiting
  • HIV-1-infection
  • ChAdOx1.tHIVconsv1
  • +7 more
  • San Diego, California
  • +11 more
Oct 4, 2023

HIV-1-infection Trial in Botswana, Malawi, South Africa (3BNC117-LS-J, 10-1074-LS-J, Placebo for 3BNC117-LS-J)

Not yet recruiting
  • HIV-1-infection
  • Molepolole, Botswana
  • +8 more
Sep 8, 2023

Acute HIV Infection Trial in Brazil, Peru, United States (biological, other, drug)

Not yet recruiting
  • Acute HIV Infection
  • VRC07-523LS
  • +3 more
  • Birmingham, Alabama
  • +35 more
Jan 30, 2023

Hepatitis B, HIV Trial in Worldwide (Selgantolimod, Placebo)

Recruiting
  • Hepatitis B
  • HIV Infections
  • San Diego, California
  • +35 more
Jan 31, 2023

HIV Trial in South Africa (VRC01.23LS, PGT121.414.LS, PGDM1400LS)

Not yet recruiting
  • HIV Infections
  • VRC01.23LS
  • +2 more
  • Cape Town, Western Cape, South Africa
  • +7 more
Jul 24, 2023

HIV Trial in Worldwide (Oral Cabotegravir (CAB), Oral Rilpivirine (RPV), Long-Acting Injectable Cabotegravir (CAB LA))

Recruiting
  • HIV Infections
  • Oral Cabotegravir (CAB)
  • +4 more
  • La Jolla, California
  • +30 more
Feb 2, 2023

HIV Infection, Hepatitis B Trial in Worldwide (HEPLISAV-B, ENGERIX-B)

Recruiting
  • HIV Infection
  • Hepatitis B
  • HEPLISAV-B
  • ENGERIX-B
  • Birmingham, Alabama
  • +47 more
Dec 13, 2022

PREPARE (A5361s) Substudy of REPRIEVE (A5332)

Active, not recruiting
  • HIV-1 Infection
  • Birmingham, Alabama
  • +32 more
Dec 7, 2022

Hepatitis C Infection, HIV Infection Trial in Brazil, Puerto Rico, United States (Glecaprevir/Pibrentasvir (G/P), Ribavirin

Recruiting
  • Hepatitis C Infection
  • HIV Infection
  • Glecaprevir/Pibrentasvir (G/P)
  • Ribavirin (RBV)
  • San Diego, California
  • +15 more
Dec 19, 2022

HIV-1-infection Trial in United States (CVC 150 mg, CVC 300 mg, Placebo for CVC 150 mg)

Not yet recruiting
  • HIV-1-infection
  • CVC 150 mg
  • +3 more
  • Los Angeles, California
  • +16 more
Nov 22, 2022

HIV Trial in Worldwide (VRC01, VRC01LS, VRC07-523LS)

Completed
Has Results
  • HIV Infections
  • VRC01
  • +2 more
  • Los Angeles, California
  • +13 more
Dec 19, 2022

HIV-1-infection Trial in Worldwide (Once daily CAB tablet + RPV tablet, Long acting CAB injectable + long acting RPV injectable)

Not yet recruiting
  • HIV-1-infection
  • Once daily CAB tablet + RPV tablet
  • Long acting CAB injectable + long acting RPV injectable
  • Atlanta, Georgia
  • +11 more
Dec 13, 2022

HIV Infection Trial in Brazil, Peru, United States (Analytical Treatment Interruption)

Recruiting
  • HIV Infection
  • Analytical Treatment Interruption
  • Los Angeles, California
  • +11 more
Jan 13, 2023

Metastatic Pancreatic Adenocarcinoma Trial in Baltimore (Epacadostat, Pembrolizumab, CRS-207)

Active, not recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • Baltimore, Maryland
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jan 3, 2023

Tuberculous Meningitis Trial in Worldwide (Rifampicin (RIF), Isoniazid (INH), Linezolid (LZD))

Not yet recruiting
  • Tuberculous Meningitis
  • Rifampicin (RIF)
  • +6 more
  • Porto Alegre, Brazil
  • +9 more
Dec 14, 2022

Tuberculosis, Multidrug-Resistant, Tuberculosis, Tuberculosis, Pulmonary Trial in Worldwide (Linezolid 600 mg, Linezolid 1200 mg

Recruiting
  • Tuberculosis, Multidrug-Resistant
  • +2 more
  • Linezolid 600 mg
  • +7 more
  • Gaborone, South-East District, Botswana
  • +16 more
Dec 13, 2022

Tuberculosis, MDR Trial in Worldwide (Delamanid (DLM), Isoniazid (INH), Pyridoxine (vitamin B6))

Recruiting
  • Tuberculosis, MDR
  • Delamanid (DLM)
  • +2 more
  • Gaborone, South-East District, Botswana
  • +26 more
Sep 22, 2022

HIV Trial in Philadelphia (3BNC117-LS, 10-1074-LS)

Suspended
  • HIV Infections
  • Birmingham, Alabama
  • +5 more
Jan 31, 2023

Hepatitis B Virus Trial in Puerto Rico, United States (Cemiplimab)

Suspended
  • Hepatitis B Virus
  • Cemiplimab
  • Los Angeles, California
  • +6 more
Dec 5, 2022

HIV-1-infection, Adiposity, Insulin Resistance Trial in Brazil, United States (Semaglutide)

Active, not recruiting
  • HIV-1-infection
  • +4 more
  • Birmingham, Alabama
  • +7 more
Dec 7, 2022

Tenofovir on Bone Health and Kidneys During Pregnancy and

Completed
  • HIV Infections
  • Tenofovir disoproxil fumarate (TDF)
  • Blantyre, Malawi
  • +10 more
Sep 22, 2022

HIV I Infection Trial in United States (VIR-1388, Placebo)

Not yet recruiting
  • HIV I Infection
  • VIR-1388
  • Placebo
  • Birmingham, Alabama
  • +5 more
May 2, 2023

Monkeypox Trial in Puerto Rico, United States (Tecovirimat Oral Capsule, Placebo, Tecovirimat Oral Capsule (Open Label))

Recruiting
  • Monkeypox
  • Tecovirimat Oral Capsule
  • +2 more
  • Birmingham, Alabama
  • +61 more
Sep 12, 2022

Ovarian Cancer, Drug Related Tumor/Cancer Trial (secondary cytoreductive surgery, chemo)

Not yet recruiting
  • Ovarian Cancer
  • Drug Related Neoplasm/Cancer
  • (no location specified)
Jan 28, 2023